Literature DB >> 10704229

The process of amyloid-like fibril formation by methionine aminopeptidase from a hyperthermophile, Pyrococcus furiosus.

K Yutani1, G Takayama, S Goda, Y Yamagata, S Maki, K Namba, S Tsunasawa, K Ogasahara.   

Abstract

Amyloid is associated with serious diseases including Alzheimer's disease and senile-systemic amyloidosis due to misfolded proteins. In the course of study of the denaturation process of methionine aminopeptidase (MAP) from the hyperthermophile P. furiosus, we found that MAP forms amyloid-like fibrils, and we then investigated the mechanism of amyloid fibril formation. The kinetic experiments on denaturation monitored by CD at 222 nm indicated that MAP in the presence of 3.37 M GuHCl at pH 3.31 changed to a conformation containing a considerable content of beta-sheet structure after the destruction of the alpha-helical structure. MAP in this beta-rich conformation was highly associated, and its stability was remarkably high: the midpoint of the GuHCl denaturation curve was 4.82 M at pH 3.0, and a thermal transition was not observed up to 125 degrees C by calorimetry. The amyloid-like fibril formation of MAP was confirmed by Congo red staining with a typical peak at 542 nm in the difference spectrum, showing a cross-beta X-ray diffraction pattern with a clear sharp reflection at 4.7 A and a characteristic unbranched fibrillar appearance with a length of about 1000 A and a diameter of about 70 A in the electron micrographs. Present results indicate that the amyloid-like form of MAP appears just after the protein is almost completely denatured, and even highly stable proteins can also form amyloid-like conformation under conditions where the denatured state of the protein is abundantly populated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704229     DOI: 10.1021/bi991406v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

2.  Amyloid formation in denatured single-mutant lysozymes where residual structures are modulated.

Authors:  Tomonori Mishima; Takatoshi Ohkuri; Akira Monji; Taiji Imoto; Tadashi Ueda
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

3.  Amyloid fibril formation in vitro from halophilic metal binding protein: its high solubility and reversibility minimized formation of amorphous protein aggregations.

Authors:  Yuhei Tokunaga; Mitsuharu Matsumoto; Masao Tokunaga; Tsutomu Arakawa; Yasushi Sugimoto
Journal:  Protein Sci       Date:  2013-09-30       Impact factor: 6.725

4.  Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain.

Authors:  F Chiti; M Bucciantini; C Capanni; N Taddei; C M Dobson; M Stefani
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

5.  Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation.

Authors:  F Chiti; N Taddei; M Stefani; C M Dobson; G Ramponi
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

6.  UV-light exposed prion protein fails to form amyloid fibrils.

Authors:  Abhay Kumar Thakur; Ch Mohan Rao
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.